immucell
announces
preliminary
unaudited
sales
results
quarter
ended
september
portland
maine
globe
newswire
immucell
corporation
nasdaq
iccc
immucell
company
growing
animal
health
company
develops
manufactures
markets
practical
products
improve
health
productivity
dairy
beef
calves
today
announced
preliminary
unaudited
sales
results
third
quarter
ended
september
understanding
immucell
financial
performance
pandemic
great
interest
investors
company
providing
preliminary
look
top
line
results
early
reporting
period
company
expects
offer
preliminary
sales
information
close
fourth
quarter
plans
return
standard
disclosure
practice
product
sales
results
total
product
sales
increased
million
period
ended
september
versus
comparable
period
total
product
sales
increased
million
million
period
ended
september
versus
comparable
period
total
product
sales
increased
million
million
trailing
period
ended
september
versus
trailing
period
ended
september
management
discussion
indicated
continued
top
line
growth
sales
team
able
pivot
safe
successful
despite
impact
work
commented
michael
brigham
president
ceo
longer
trailing
periods
growth
generated
first
provides
antibodies
without
vaccination
every
calf
receives
measured
dose
immediate
three
primary
pathogens
coli
coronavirus
reduced
backlog
orders
worth
approximately
million
march
approximately
june
approximately
september
concluded
brigham
budget
come
capacity
month
despite
related
delays
equipment
manufacturer
deferred
installation
increase
liquid
processing
capacity
critical
supply
needs
second
quarter
first
quarter
build
needed
inventory
incurring
required
transitional
shut
impacted
operations
move
equipment
achieve
usda
site
license
conference
call
interested
parties
access
conference
call
scheduled
company
review
full
third
quarter
financial
results
dialing
toll
free
international
et
friday
november
teleconference
replay
call
available
seven
days
toll
free
international
utilizing
confirmation
investors
encouraged
review
company
form
period
ended
september
expects
file
sec
thursday
november
updated
corporate
presentation
slide
deck
provides
overview
company
business
available
investors
tab
company
website
request
company
immucell
immucell
corporation
nasdaq
iccc
purpose
create
practical
products
improve
health
productivity
dairy
beef
calves
immucell
manufactures
markets
first
providing
immediate
newborn
dairy
beef
calves
late
stages
developing
novel
treatment
subclinical
mastitis
without
milk
discard
requirement
provides
alternative
traditional
antibiotics
press
releases
information
company
available
http
contacts
michael
brigham
president
ceo
immucell
corporation
joe
diaz
robert
blum
joe
dorame
lytham
partners
llc
iccc
